Slightly more than half of children under 15 years of age living with HIV are on antiretroviral medications

Fast fact:
  • Of the 1.68 million [confidence bounds: 1.35 million–2.08 million] children aged 0-14 living with HIV globally, only 52 per cent [42–65 per cent] were receiving life-saving antiretroviral therapy (ART) in 2021.

Globally, children under age 15 account for about 5 per cent of all people living with HIV, 10 per cent of new HIV infections and 15 per cent of all AIDS-related deaths. Children under 1 year of age are among those most vulnerable to HIV. Evidence shows that early initiation of antiretroviral drugs in infants with HIV can save lives; yet coverage of critical intervention among children remains too low. Due to the slow progress reported in scaling up access to treatment for children living with HIV, the 90-90-90 treatment targets, which called for 90 per cent of those living with HIV to know their status, 90 per cent of those who know their status to be on treatment, and 90 per cent of those on treatment to be virally suppressed and sustained, were not met. However, there has been a renewed focus to meet 95-95-95 targets by 2025 including the launch of the Global Alliance to End AIDS in children.

Renewed focus has been called to strategically target more decentralized diagnostics and clinical management for children exposed and living with HIV, as well as integration with maternal, child and adolescent services at facilities and within communities. The 2025 targets underscore the need to remove societal and legal barriers to service delivery, as well as recognize that the HIV response is essential in the wider effort to realize the right to health and other human rights and other goals within the 2030 Agenda for Sustainable Development.


  • Data explorer

    Build your own dataset

    Build and download your own customizable dataset on hiv/aids data

  • Key HIV epidemiology indicators for children and adolescents aged 0-19, 2000-2021

    Download spreadsheet
  • Early Infant Diagnosis for HIV, 2010-2021

    Download spreadsheet
  • Antenatal care (ANC) based HIV testing for pregnant women, 2015–2021

    Download spreadsheet
  • Coverage of prevention of mother-to-child transmission (PMTCT), 2010-2021

    Download spreadsheet
  • Coverage of antiretroviral treatment (ART) among children aged 0-14 living with HIV, 2010-2021

    Download spreadsheet
  • Coverage of antiretroviral treatment (ART) among adolescents aged 10-19 living with HIV, 2010-2021

    Download spreadsheet
  • Key indicators in adolescent HIV prevention, 2000-2021

    Download spreadsheet
  • Number of children aged 0-17 who have lost one or both parents, by cause, 1990-2021

    Download spreadsheet
  • Proportion of people expressing discriminatory attitudes towards people living with HIV, 2014-2021

    Download spreadsheet

Data sources + methodology

Global AIDS monitoring 2022

In order to monitor the HIV response and progress towards achieving global goals, countries submit national and subnational data on a host of indicators to the Global AIDS Monitoring (GAM) system. Annual submissions are reviewed and validated. Data consist of programmatic data for HIV prevention, testing and treatment. Other indicators require data from population-based surveys and surveys focused on key populations at risk of HIV infection.

For more information, click here.

UNAIDS Estimates and Spectrum’s AIDS Impact Model

Each year countries update their AIDS Impact Model in Avenir Health’s Spectrum software to develop the latest estimates for the HIV epidemic. Supported by UNAIDS, WHO and UNICEF these estimates are used to inform programme and policy decisions for HIV epidemic response.

Useful links:

Methods for HIV modelling are developed by the UNAIDS Reference Group on Estimates, Modelling and Projections.

All available data on HIV estimates are available at

Nationally representative surveys

Multiple Indicator Cluster Surveys (MICS), Demographic and Health Surveys (DHS), AIDS Indicator Surveys (AIS), Population-based HIV Impact Assessments (PHIA) reproductive health surveys, sexual behaviour surveys and other nationally representative surveys are currently used to collect data on HIV and AIDS.